Observational studyThe Journal of international medical research2022

Adverse events after administration of the first and second doses of messenger RNA-based COVID-19 vaccines in Japanese subjects aged 12-18 years.

Taku Ogawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.